Abstract
Drug efflux is an important resistance mechanism in Mycobacterium tuberculosis. We found that verapamil, an efflux inhibitor, profoundly decreases the MIC of bedaquiline and clofazimine to M. tuberculosis by 8- to 16-fold. This exquisite susceptibility was noted among drug-susceptible and drug-resistant clinical isolates. Thus, efflux inhibition is an important sensitizer of bedaquiline and clofazimine, and efflux may emerge as a resistance mechanism to these drugs. © 2014, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Gupta, S., Cohen, K. A., Winglee, K., Maiga, M., Diarra, B., & Bishai, W. R. (2014). Efflux inhibition with verapamil potentiates bedaquiline in mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 58(1), 574–576. https://doi.org/10.1128/AAC.01462-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.